PharmiWeb

Global Minimally Invasive Surgery Market to Reach US$211.24 Billion by 2033, Says FutureWise Research

FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...
PharmiWeb

GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLYGENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in ...
PharmiWeb

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the ...
PharmiWeb

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading AI-powered engine for scientific product insights, proudly announces the deployment of 1,000 Bioz Badges on Multi ...
PharmiWeb

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
PharmiWeb

Sub-Saharan Africa Pharmaceuticals Market Industry Analysis , Opportunity Assessment And Forecast Till 2030: Medi-tech Insights

Sub-Saharan Africa Pharmaceuticals Market OutlookThe Sub-Saharan Africa (SSA) pharmaceuticals market is poised for strong expansion over the coming years, reflecting the region’s evolving healthcare ...
PharmiWeb

Atherectomy Devices Market to Witness a Leap by Leaching CAGR of 8% By The End Of 2029

Global Atherectomy Devices Market OverviewThe global atherectomy devices market is expected to witness substantial growth, with a projected CAGR of around 8% during the forecast period. Several key ...
PharmiWeb

Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia

Trial aims to enroll 12 children at eight sites in EU and USPhase 3 trial in adult patients also planned for 2026 with focus on limb sparing associated with bone non-union (BNU)Novadip aims to become ...
PharmiWeb

Biovica Signs Client Bill Agreement with Leading U.S. NCI-Designated Cancer Center

UPPSALA, SE / ACCESS Newswire / December 15, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announced that the company ...
PharmiWeb

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd , has entered into two strategic agreements with privately held Hasten ...
Opinion
PharmiWebOpinion

Budget speculation kills growth

Budget speculation kills growth Responding to the latest growth figures, Julian Jessop, Economics Fellow at the Institute of Economic Affairs said: "The further contraction in the UK economy in ...
PharmiWeb

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official ...